Intended for healthcare professionals

Innovation.
Backed by evidence.

Robotic-assisted bronchoscopy (RAB) is effective, efficient, and safe.

  • Improves how you can reach and biopsy lung nodules beyond where traditional bronchoscopes can reach, including the periphery of the lung1,2

  • Enables staging in 1 procedure1

  • Lower rates of pneumothorax1,3,4
MONARCH platform surgical tools

Late-stage detection negatively impacts lung cancer survival rates⁵

48%

of lung nodules are located in the peripheral third of the lung6

46%

of patients receive 2 or more biopsies7

Finding small lung nodules earlier creates the opportunity to accelerate treatment decisions⁸

#1

Lung cancer is the leading cancer killer globally9

4 mins

Every 4 MINUTES someone in the US dies of lung cancer10

2 mins

Every 2 MINUTES someone will be diagnosed with lung cancer11

134,592

deaths from lung cancer in the US annually12

Want to get involved?

Interested in pursuing and publishing original research? Visit our clinical investigator page
to learn more about getting involved in the study process.

Learn more

J&J is committed to the pursuit of clinical evidence to change the course of lung cancer and supports unique, non-duplicative, independent clinical research studies of scientific and business merit with grants providing either funding and/or product(s).

Explore the compendium
of clinical data

>80% diagnostic yield was obtained even in lesions in the outer third of the lung and right upper lobe

MONARCH demonstrated a high diagnostic yield in the largest study to date (264 patients), despite representing a real-world community population with a relatively low prevalence of cancer.8

Low risk for complications: 4.7% rate of pneumothorax, 2.6% rate of bleeding

This multicenter, prospective, single-arm, observational study enrolled 681 patients with 8- to 50-mm lung lesions deemed appropriate for a bronchoscopic approach to diagnosis.13

Successful lesion localization was achieved in 96.2% of cases

The first, prospective, multicenter study of robotic-assisted bronchoscopy (RAB) included 54 patients with peripheral pulmonary lesions. The adverse event rate was comparable with conventional bronchoscopic procedures.14

The number of patients treated increased
by 26.7-fold with robotic-assisted bronchoscopy program

A single-center, retrospective study of 616 patients treated in a community hospital with a single interventional pulmonologist was performed to analyze economic impact of a robotic-assisted bronchoscopy (RAB) program. The utilization growth was compared to numbers from 208 before the RAB program was implemented.15

Improved brochoscope reach was established using robotic-assisted bronchoscopy

Assessed the reach of a robotic endoscopic system within human cadaveric lungs compared with conventional thin bronchoscopes.16

Supporting documentation

PDF

Explore the Compendium of Clinical Data Supporting the Efficacy, Safety, and Outcomes of the MONARCH Platform
Select all (1)

References

Bronchoscopy Indications for Use: The MONARCH™ Bronchoscope and the MONARCH™ Platform and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures.

Bronchoscopy Important Safety Statement: Complications from bronchoscopy may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. More serious complications from bronchoscopy may include collapsed lung, respiratory failure, hemorrhage, burns, heart attack, or cardiac arrhythmia.


  1. Folch EE, Pritchett MA, Nead MA, et al. Electromagnetic navigation bronchoscopy for peripheral pulmonary lesions: one-year results of the prospective, multicenter NAVIGATE study. J Thorac Oncol. 2019;14(3):445-458.
  2. Pyarali FF, Hakami-Majd N, Sabbahi W, Chaux G. Robotic-assisted navigation bronchoscopy: a meta-analysis of diagnostic yield and complications.J Bronchology Interv Pulmonol. 2024;31(1):70-81
  3. Ho AT, Gorthi R, Chawla M, Patolia S. Solitary lung nodule: CT-guided transthoracic biopsy vs transbronchial biopsy with endobronchial ultrasound and Hexible bronchoscope, a meta-analysis of randomized controlled trials. Lung. 2023;201(1):85-93.
  4. DiBardino DM, Yarmus LB, Semaan RW. Transthoracic needle biopsy of the lung. J Thorac Dis. 2015;7 (supp| 4):S304-S316
  5. Cancer stat facts: lung and bronchus cancer. Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute (NCI). Accessed October 7, 2025. 
  6. Murgu S, Sterman D, Yasufuku K, et al. Demographic and lesion characteristics in the first 443 subjects enrolled in a multicenter observational real-world robotic bronchoscopy study: interim results from TARGET. Poster presented at: 2022 AABIP Annual Conference; August 11-13, 2022; Nashville, TN.
  7. Zhang Y, Shi L, Simoff MJ, Wagner OJ, Lavin J. Biopsy frequency and complications among lung cancer patients in the United States. Lung Cancer Manag.2020;9(4):LMT40
  8. Khan F, Seaman J, Hunter TD, et al. Diagnostic outcomes of robotic-assisted bronchoscopy for pulmonary lesions in a real-world multicenter community setting.BMC Pulm Med. 2023:23(1):161.
  9. Cancer. World Health Organization (WHO). February 3, 2022. Accessed October 7, 2025. 
  10. Lung cancer facts you should know. Lung Cancer Foundation of America (LCFA). Accessed October 7, 2025.
  11. State of lung cancer: lung cancer key findings. American Lung Association (ALA). Accessed October 7, 2025.
  12. Lung cancer trends brief: mortality. American Lung Association (ALA). Accessed October 7, 2025 
  13. Murgu SD, Chen AC,  Connelly J, et al. Safety results from multi-center observational real-world robotic bronchoscopy (TARGET) study. Poster presented at CHEST 2023; October 8-11, 2023; Honolulu; HI.
  14. Chen AC, Pastis NJ, Silvestri GA, et al. Robotic bronchoscopy for peripheral pulmonary lesions: a multicenter pilot and feasibility study (BENEFIT). Chest. 2021;159(2):845-852.
  15. Khan F, Tan Z, Amos T, et al. Community hospital experience with robotic bronchoscopy: an analysis of utilization patterns. Poster presented at CHEST 2023; October 8-11, 2023; Honolulu, HI.
  16. Chen AC, Gillespie CT. Robotic endoscopic airway challenge: REACH assessment. Ann Thorac Surg. 2018;106(1):293-297.


For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.

US_SRG_RADS_389159.1